Related Experiment Video
Updated: Mar 24, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
[High levels of atrial natriuretic peptide and copeptin and mortality risk]
Corsino Rey1, Clara García-Cendón2, Pablo Martínez-Camblor3
1Unidad de Cuidados Intensivos Pediátricos, Hospital Universitario Central de Asturias, Oviedo, Asturias, España; Universidad de Oviedo, Oviedo, Asturias, España; Red SAMID II, Instituto de Salud Carlos III, Madrid, España.
Insights
High levels of mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and procalcitonin (PCT) indicate increased mortality risk in critically ill children. MR-proANP showed a stronger association with organ failure than copeptin.
Area of Science:
- Biomarkers in critical care medicine
- Pediatric critical illness research
- Prognostic indicators in intensive care
Background:
- Biomarkers are crucial for assessing prognosis in critically ill children.
- Mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and procalcitonin (PCT) are potential indicators of critical illness severity.
- Understanding the association of these biomarkers with mortality risk is vital for clinical decision-making.
Purpose of the Study:
- To investigate the association between elevated plasma concentrations of MR-proANP, copeptin, and PCT and the risk of mortality in critically ill children.
- To compare the predictive value of these biomarkers in relation to mortality risk and organ failure.
- To evaluate MR-proANP, copeptin, and PCT as prognostic tools in pediatric intensive care.
Main Methods:
- A prospective observational study was conducted on 254 critically ill children.
- Plasma concentrations of MR-proANP, copeptin, and PCT were measured.
- Children were stratified into high (Group A) and low (Group B) mortality risk groups, and by the number of failing organs (Group 1: >1 organ, Group 2: <2 organs).
Main Results:
- Significantly higher median plasma levels of MR-proANP, copeptin, and PCT were observed in the high mortality risk group (Group A) compared to the low mortality risk group (Group B) (P<.001 for all).
- The area under the curve (AUC) for differentiating mortality risk was highest for PCT (0.842), followed by MR-proANP (0.764) and copeptin (0.735).
- MR-proANP demonstrated a statistically significant higher AUC (0.837) than copeptin (0.735) in differentiating between patients with failure of more than 1 organ versus less than 2 organs (P=.01).
Conclusions:
- Elevated plasma concentrations of MR-proANP, copeptin, and PCT are associated with increased mortality risk in critically ill children.
- PCT and MR-proANP show strong potential as prognostic biomarkers in this population.
- MR-proANP exhibits a stronger association with the extent of organ failure compared to copeptin.
Objective:
To determine whether high levels of mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and procalcitonin (PCT) plasma concentrations are associated with increased mortality risk.
Methods:
Prospective observational study including 254 critically ill children. MR-proANP, copeptin and PCT were compared between children with high (Group A; n=33) and low (Group B; n=221) mortality risk, and between patients with failure of more than 1 organ (Group 1; n=71) and less than 2 (Group 2; n=183).
Results:
Median (range) of MR-proANP, copeptin, and PCT levels in group A vs B were, respectively: 209.4 (30.5-1415.8) vs. 75.0 (14.6-867.2) pmol/L (P<.001); 104.4 (7.4-460.9) vs. 26.6 (0.00-613.1) pmol/L (P<.001), and 7.8 (0.3-552.0) vs. 0.3 (0.02-107.0) ng/mL (P<.001). The area under the curve (AUC) for the differentiation of group A and B was 0.764 (95% CI: 0.674-0.854) for MR-proANP; 0.735 (0.642-0.827) for copeptin, and 0.842 (0.744-0.941) for PCT, with no statistical differences. The AUCs for the differentiation of group 1 and 2 were: 0.837 (0.784-0.891) for MR-proANP, 0.735 (0.666-0.804) for copeptin, and 0.804 (0.715-0.892) for PCT, with statistical differences between MR-proANP and copeptin, P=.01.
Conclusions:
High levels of MR-proANP, copeptin and PCT were associated with increased mortality risk scores. MR-proANP showed a higher association than copeptin with number of organs in failure.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

